Sampre Nutritions Limited (BOM:530617)
India · Delayed Price · Currency is INR 5.70
-0.16 (-2.73%)
At close: Aug 21, 2026
Sampre Nutritions Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 473.29 | 433.47 | 251.24 | 251.47 | 371.07 | 231.26 | |
Revenue Growth | 50.40% | 72.53% | -0.09% | -32.23% | 60.46% | 26.83% |
Cost of Revenue | 173.04 | 315.79 | 229.77 | 166.1 | 287.81 | 167.33 |
Gross Profit | 300.25 | 117.69 | 21.48 | 85.37 | 83.25 | 63.92 |
Selling, General & Admin | 153.01 | 39.8 | 30.36 | 28.78 | 23.95 | 19.07 |
Other Operating Expenses | 98.49 | 30.31 | 29.75 | 15.34 | 18.75 | 9.67 |
Operating Expenses | 273.15 | 90.56 | 79.81 | 62.45 | 60.92 | 45.08 |
Operating Income | 27.1 | 27.12 | -58.34 | 22.92 | 22.34 | 18.84 |
Interest Expense | -13.17 | -11.16 | -16.98 | -19.04 | -17.77 | -17.16 |
Interest & Investment Income | - | 0.53 | 2.81 | 0.37 | 0.02 | 0.04 |
Other Non Operating Income (Expenses) | 4.74 | 1.28 | -2.74 | -0.08 | -0.41 | 2.23 |
EBT Excluding Unusual Items | 18.68 | 17.77 | -75.25 | 4.17 | 4.18 | 3.95 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.23 |
Other Unusual Items | - | - | - | 0.7 | - | - |
Pretax Income | 18.68 | 17.77 | -75.25 | 4.87 | 4.18 | 3.72 |
Income Tax Expense | -12.04 | -13 | 1.47 | 2.56 | 0.7 | 0.64 |
Net Income | 30.71 | 30.77 | -76.72 | 2.32 | 3.47 | 3.08 |
Net Income to Common | 30.71 | 30.77 | -76.72 | 2.32 | 3.47 | 3.08 |
Net Income Growth | - | - | - | -33.33% | 12.86% | 306.61% |
Shares Outstanding (Basic) | - | 14 | 14 | 27 | 23 | 19 |
Shares Outstanding (Diluted) | - | 14 | 14 | 27 | 38 | 19 |
Shares Change | - | - | -48.55% | -26.83% | 94.80% | - |
EPS (Basic) | - | 2.18 | -5.43 | 0.08 | 0.15 | 0.16 |
EPS (Diluted) | - | 2.18 | -5.43 | 0.08 | 0.09 | 0.16 |
EPS Growth | - | - | - | -8.89% | -42.06% | 306.61% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -33.83 | -1.93 | 2.44 | -35.27 | 11.07 |
Free Cash Flow Per Share | - | -2.39 | -0.14 | 0.09 | -0.94 | 0.57 |
Gross Margin | 63.44% | 27.15% | 8.55% | 33.95% | 22.44% | 27.64% |
Operating Margin | 5.73% | 6.26% | -23.22% | 9.11% | 6.02% | 8.15% |
Profit Margin | 6.49% | 7.10% | -30.54% | 0.92% | 0.94% | 1.33% |
Free Cash Flow Margin | - | -7.80% | -0.77% | 0.97% | -9.51% | 4.79% |
EBITDA | 47.75 | 47.58 | -38.63 | 41.25 | 40.55 | 35.18 |
EBITDA Margin | 10.09% | 10.98% | -15.38% | 16.40% | 10.93% | 15.21% |
D&A For EBITDA | 20.65 | 20.46 | 19.7 | 18.33 | 18.22 | 16.34 |
EBIT | 27.1 | 27.12 | -58.34 | 22.92 | 22.34 | 18.84 |
EBIT Margin | 5.73% | 6.26% | -23.22% | 9.11% | 6.02% | 8.15% |
Effective Tax Rate | - | - | - | 52.48% | 16.83% | 17.30% |
Revenue as Reported | 478.03 | 437.79 | 254.99 | 252.65 | 371.79 | 234.03 |
Advertising Expenses | - | 0.09 | 0.43 | 0.35 | 0.57 | 0.2 |